SCHEMBL101278

SCHEMBL101278

CC[CH]CCCCCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
THRB P10828 1/20 0.50
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
DNM1 Q05193 3/20 0.45
EP300 Q09472 1/20 0.41
GMNN O75496 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
APEX1 P27695 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL103010 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL200754 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL102975 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25177168 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL10582094 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25171019 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL100176 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25173992 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL201237 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL101987 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108359256-B Emulsified modified asphalt based on zwitterionic Gemini emulsifier and preparation method thereof 鄂尔多斯市路泰新材料科技发展有限公司 2020-12-29 CN claimed
CN-112029302-A Zwitterionic Gemini emulsifier and application thereof in asphalt 湖南辰砾新材料有限公司 2020-12-04 CN claimed
CN-107001622-B Novel polymers containing grafted sodium or lithium bis (sulfonyl) imide salts, method for the production thereof and use thereof as battery electrolytes CDP创新公司 2020-01-07 CN claimed
CN-108559012-A Synthetic lubricant base oil metallocene poly-alpha olefins catalyst and its preparation and application 亚培烯科技(杭州)有限公司 2018-09-21 CN claimed
EP-2740479-B1 COMPOSITION CONTAINING ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLINE FOR BOOSTING IMMUNITY OR TREATMENT OF BACTERIAL INFECTIONS ARIBIO INC (KR) 2017-10-25 EP claimed
CN-106146692-A Synthetic lubricant base oil metallocene poly-alpha olefins catalyst and its preparation method and application 苏州亚培克生物科技有限公司 2016-11-23 CN claimed
CN-106046211-A Metallocene poly-alpha olefin catalyst for synthesizing lubricating oil base oil and preparation method and application thereof 苏州亚培克生物科技有限公司 2016-10-26 CN claimed
CN-105400133-A Method for enhancing carbon fiber resin based composite material through organic modified nano-particles HENGSHEN CO LTD 2016-03-16 CN claimed
CN-105384611-A Electron donor of Ziegler-Natta catalyst and preparation method of electron donor SUZHOU APAC BIOLOGICAL SCIENCE & TECH CO LTD 2016-03-09 CN claimed
EP-2740479-A2 COMPOSITION CONTAINING ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLINE FOR BOOSTING IMMUNITY OR TREATMENT OF BACTERIAL INFECTIONS Arimed Inc. (KR) 2014-06-11 EP claimed
US-20140134210-A1 COMPOSITION CONTAINING ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLINE FOR BOOSTING IMMUNITY OR TREATMENT OF BACTERIAL INFECTIONS ARIMED INC. (KR) 2014-05-15 US claimed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP claimed
CN-118355051-A Polycarbonate resin composition 三菱化学株式会社 2024-07-16 CN disclosed
EP-4384575-A1 LASER TRANSPARENT COMPOSITION AND MOLDED ARTICLES MADE THEREFROM Celanese International Corporation (US) 2024-06-19 EP disclosed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
CN-117916286-A Polycarbonate resin composition 三菱化学株式会社 2024-04-19 CN disclosed
US-4154756-A HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1979-05-15 US disclosed
US-4136256-A HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC AMERICAN CYANAMID COMPANY (US) 1979-01-23 US disclosed
US-4117158-A ANTILIPEMIC AGENTS AMERICAN CYANAMID COMPANY (US) 1978-09-26 US disclosed
US-3993707-A EPOXY RESIN, FATTY AMINE, AND AMINE CURING AGENT PACIFIC VEGETABLE OIL CORPORATION (US) 1976-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140134210-A1 COMPOSITION CONTAINING ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLINE FOR BOOSTING IMMUNITY OR TREATMENT OF BACTERIAL INFECTIONS LPCAT1, PHOSPHO1, LPCAT3 TSHR 4595/4885THRB 4164/4885FAAH 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.